Clinical Trial Detail

NCT ID NCT01014065
Title A Prospective Study of Acute Cardiovascular Effects of First-line Sunitinib in Metastatic Renal Cell Carcinoma Patients (SUnitinib Prospective CardiovasculaR Effect)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors AHS Cancer Control Alberta
Indications

renal cell carcinoma

Therapies

Sunitinib

Age Groups: adult

No variant requirements are available.